This thread is for the new lotion CUV9900, being developed by Clinuvel which provides the user with a "protective" suntan.
This is going to be revolutionary and disruptive to a number of HUGE existing industries - tanning salons, sunscreen lotions for starters.
CUV9900 is an alpha-Melanocyte Stimulating Hormone (alpha-MSH) analogue which the company intends will complement Clinuvel's lead product SCENESSE® (afamelanotide). It belongs to the same family of molecules, known as melanocortins, as afamelanotide.
Recent research has shown that CUV9900 is a potent skin protectant. Clinuvel intends to launch CUV9900 in various new formulations. Formulation work has commenced and Clinuvel expects the first formulations to be available for clinical testing after the commercialisation of its lead product.
CUV Price at posting:
$4.76 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)